Development of neurotrophic molecules for treatment of neurodegeneration

Current Protein and Peptide Science

Volumn 2, Issue 3, 2001, Pages 261-276

  Chen, Z Y ^a   Cao, L ^a   Wang, L M ^a   Guo, C ^a   Ye, J L ^a   Chai, Y F ^a   Yan, Z Y ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; CYTOKINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LIPOPOLYSACCHARIDE; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; NEUROTROPHIN 6; NEUROTROPHIN 7; OKADAIC ACID; PURINE DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; NERVE GROWTH FACTOR RECEPTOR;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CACHEXIA; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIABETIC NEUROPATHY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; LABORATORY; MIDDLE EAR DISEASE; NEUROSCIENCE; OUTPATIENT DEPARTMENT; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; DRUG DESIGN; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR MIMICRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVIEW; X RAY CRYSTALLOGRAPHY;

ANIMAL; APOPTOSIS; CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; GENE EXPRESSION REGULATION; HUMAN; MAGNETIC RESONANCE SPECTROSCOPY; MAP KINASE SIGNALING SYSTEM; MOLECULAR MIMICRY; NERVE GROWTH FACTORS; NEURODEGENERATIVE DISEASES; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, NERVE GROWTH FACTOR; SUPPORT, NON-U.S. GOV'T;

EID: 0034856539     PISSN: 13892037     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389203013381125     Document Type: Article

References (124)